Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone

Gareth Morgan, Antonio Palumbo, Sujith Dhanasiri, Dawn Lee, Katja Weisel, Thierry Facon, Michel Delforge, Albert Oriol, Mohamed Zaki, Xin Yu, Lars Sternas, Christian Jacques, Ron Akehurst, Fritz Offner, Meletios A. Dimopoulos
  • British Journal of Haematology, November 2014, Wiley
  • DOI: 10.1111/bjh.13227
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Albert Oriol